Fundraising Fox
Figur8
Boston, US · Founded 2017 · 25 employees on LinkedIn · 11 known investors
Find your way into Figur8
Each arrow is one introduction. Sign up to fill in the first one.
Ask IC Jan to introduce you to Nan-Wei Gong
You →IC · together at Figur8 →Nan-Wei
Sign up to find every way you can get introduced to Figur8
- Your email: who you already know at Figur8, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Figur8 team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
FIGUR8 is an FDA-registered platform that provides objective, actionable insights for musculoskeletal health diagnosis and treatment. The platform originated from collaboration between MIT scientists, Massachusetts General Hospital, and the Boston Red Sox, and is now adapted for use across any point of care.
Also known as FIGUR8
Founders & leadership
Figur8 was founded in 2017 by Nan-Wei Gong.
Investors · 11
How we know: the company's own site · First Spark Ventures, Llc's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Phoenix Venture Partners's portfolio page · the company's own site · Not right? Tell us
How we know: Chloe Capital's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Evolution VC Partners's portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: Taiwan Global Angels's portfolio page · Not right? Tell us
How we know: The E14 Fund's portfolio page · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements$33.1M disclosed across 4 of 5 rounds · 2017–2023
- Undisclosed amountSeed FundingAug 2019Source ↗
▶$24.6MraisedAug 2023 · 18 investors · OtherRule 506(b)
- Nan-Wei GongExecutive Officer, Director
- Christina JenkinsDirector
- Manish KothariDirector
- Scott SextonExecutive Officer, Director
- Richard RubinoDirector
- Offering amount
- $24.6M
- Amount sold
- $24.6M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedNov 2020 · 14 investors · Other TechnologyRule 506(b)
- Cheng WuDirector
- Tiegeng RenExecutive Officer, Director
- Nan-Wei GongExecutive Officer, Director, Promoter
- David L. EigenDirector
- Offering amount
- $8M
- Amount sold
- $6.2M
- Proceeds to insiders
- $500K
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1.5MraisedFeb 2020 · 6 investors · Other TechnologyRule 506(b)
- David L. EigenDirector
- Tiegeng RenDirector
- Nan-Wei GongExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$825KraisedJan 2017 · 3 investors · Other TechnologyRule 506(b)
- Nan-Wei GongExecutive Officer, Director
- Amount sold
- $825K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026FIGUR8 develops a musculoskeletal (MSK) health assessment system that combines on-body sensing hardware with cloud analytics to produce what the company describes as lab-grade biomechanics data. Its core product is the bioMotion Assessment Platform (bMAP), which clinicians use to measure movement and soft-tissue function, generating consistent, repeatable objective metrics rather than the subjective measures such as manual muscle testing that the company positions as the prior standard of care.
The platform is presented as the first FDA-registered objective MSK assessment designed to be practical for any point of care. Outputs include patient-facing reporting used to track recovery week to week and to inform personalized care pathways, and data intended to support clinical decisions such as readiness for surgery. Alongside clinical use, FIGUR8 targets the workers' compensation and claims context, where the data is positioned to support injury assessment, risk evaluation, claims precision and return-to-work timelines.
Business model
FIGUR8 supplies its assessment technology and reporting to care providers ("FIGUR8-enabled" clinicians and clinics) and to payers and claims stakeholders, supported by didactic courses, onsite training and ongoing provider support.
Traction
Website testimonials reference use by physical therapists, chiropractors, an orthopedic surgeon, a rehabilitation clinic network, injured workers in workers' compensation programs, a national payer executive, the insurer MAPFRE's bodily injury assessment medical service, and an NBA player.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself as the first FDA-registered accurate, objective musculoskeletal assessment practical for every point of care, replacing subjective measurement tools.
Technology
On-body sensing hardware paired with cloud analytics that measures dynamic functional activity and soft-tissue injury and recovery, delivered through the bioMotion Assessment Platform (bMAP) with real-time reporting and a movement library for comparison. The company states the assessment is FDA-registered.
Go-to-market
Partnerships with provider organizations and clinic networks (for example Physical Rehabilitation Network) and engagement with payers and insurers, supported by clinician training programs.
Physical therapists, chiropractors, orthopedic surgeons and rehabilitation clinic networks; workers' compensation payers, third-party administrators and employers; also used with athletes and in performance/gym settings.
Geography
Headquartered in Boston, United States; testimonials include a medical assessment leader at the Spanish insurer MAPFRE.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Related companies · 3
Companies working in the same space as Figur8.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase ISTTR | 2021 | $150K |
| U.S. Air ForceAir Force | Phase I | 2020 | $50K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
▸Research sources · 1
primary sources listed
- Figur8figur8tech.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Figur8 do?
- FIGUR8 provides on-body sensors and cloud analytics for objective musculoskeletal health assessment at the point of care.
- Who founded Figur8?
- Figur8 was founded by Nan-Wei Gong in 2017.
- Who are Figur8's investors?
- Figur8's investors include First Spark Ventures, Llc, Phoenix Venture Partners, Chloe Capital, Convergent Ventures, DigiTx Partners LLC, Evolution VC Partners, GRIDS Capital, Joyance Partners and 3 more.
- How much funding has Figur8 raised?
- Figur8 has disclosed $33.1M raised across 4 of its 5 known rounds.
- Where is Figur8 headquartered?
- Figur8 is headquartered in Boston, US.